Quality of Anticoagulation With Phenprocoumon and Warfarin in Left Ventricular Assist Device Patients: A Multicenter Study.

Autor:	Schlöglhofer T; From the Department of Cardiac Surgery, Medical University of Vienna, Vienna, Austria.; Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, Austria.; Ludwig Boltzmann Institute for Cardiovascular Research, Vienna, Austria., Marschütz A; From the Department of Cardiac Surgery, Medical University of Vienna, Vienna, Austria.; Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, Austria., Combs P; Section of Cardiac Surgery, University of Chicago Medical Center, Chicago, Illinois., Stonebraker C; Section of Cardiac Surgery, University of Chicago Medical Center, Chicago, Illinois., Lupo S; Section of Cardiac Surgery, University of Chicago Medical Center, Chicago, Illinois., Jeevanandam V; Section of Cardiac Surgery, University of Chicago Medical Center, Chicago, Illinois., Riebandt J; From the Department of Cardiac Surgery, Medical University of Vienna, Vienna, Austria., Schima H; From the Department of Cardiac Surgery, Medical University of Vienna, Vienna, Austria.; Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, Austria.; Ludwig Boltzmann Institute for Cardiovascular Research, Vienna, Austria., Zimpfer D; From the Department of Cardiac Surgery, Medical University of Vienna, Vienna, Austria.; Ludwig Boltzmann Institute for Cardiovascular Research, Vienna, Austria., Meehan K; Section of Cardiac Surgery, University of Chicago Medical Center, Chicago, Illinois.
Jazyk:	angličtina
Zdroj:	ASAIO journal (American Society for Artificial Internal Organs : 1992) [ASAIO J] 2023 Jun 01; Vol. 69 (6), pp. 595-601. Date of Electronic Publication: 2023 Feb 23.
DOI:	10.1097/MAT.0000000000001895
Abstrakt:	Visual Abstract: of key results. INR, international normalized ratio; TTR, time in therapeutic range; PTR, percentage of tests in range; HRAE, hemocompatibility-related adverse event; FFUV, first follow-up visit; GIB, gastrointestinal bleeding; HR, hazard ratio.http://links.lww.com/ASAIO/A961. Competing Interests: Disclosure: T.S. consultant and advisor (Medtronic Inc., Abbott Inc., and CorWave), and research grants (Medtronic Inc., Abbott Inc., and CorWave). H.S. advisor (Medtronic Inc.), and research grants (Medtronic Inc). D.Z. proctor, advisor, and speaker (Medtronic Inc., Abbott Inc., Berlin Heart, Edwards, Abiomed), and research and travel grants (Medtronic Inc. and Abbott Inc). All the other authors have no conflicts of interest to report. (Copyright © ASAIO 2023.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu